Mathula Thangarajh1, Gary L Elfring2, Panayiota Trifillis2, Joseph McIntosh2, Stuart W Peltz2. 1. From the Children's National Health System (M.T.), Washington, DC; and PTC Therapeutics Inc. (G.L.E., P.T., J.M., S.W.P.), South Plainfield, NJ. mthangar@childrensnational.org. 2. From the Children's National Health System (M.T.), Washington, DC; and PTC Therapeutics Inc. (G.L.E., P.T., J.M., S.W.P.), South Plainfield, NJ.
Abstract
OBJECTIVE: To evaluate the relationship between deficit in digit span and genotype in nonsense mutation (nm) Duchenne muscular dystrophy (DMD) (nmDMD). METHODS: We investigated the relationship between normalized digit-span forward (d-sf) and digit-span backward (d-sb) scores to the location of nmDMD mutations in 169 participants ≥5 to ≤20 years who participated in a phase 2b clinical trial. Because alternative promoters are found upstream of DMD exons 30, 45, and 63, we correlated d-sf and d-sb to the specific nmDMD mutation location. RESULTS: Participants with nm downstream of exon 30, downstream of exon 45, and downstream of exon 63 had significantly lower normalized d-sf scores (p < 0.0001). Participants with nm downstream of exon 45 in addition had significantly lower normalized d-sb score (p < 0.04). There was no significant difference in the normalized d-sb score in participants with mutations upstream or downstream of DMD exon 30 or upstream or downstream of DMD exon 63. CONCLUSION: Our data provide evidence that specific cognitive deficits correlate to genotype in individuals with nmDMD, highlighting the critical role of brain-specific dystrophin isoforms in the neurobiological manifestations of this disease. CLINICALTRIALSGOV IDENTIFIER: NCT02090959.
OBJECTIVE: To evaluate the relationship between deficit in digit span and genotype in nonsense mutation (nm) Duchenne muscular dystrophy (DMD) (nmDMD). METHODS: We investigated the relationship between normalized digit-span forward (d-sf) and digit-span backward (d-sb) scores to the location of nmDMD mutations in 169 participants ≥5 to ≤20 years who participated in a phase 2b clinical trial. Because alternative promoters are found upstream of DMD exons 30, 45, and 63, we correlated d-sf and d-sb to the specific nmDMD mutation location. RESULTS:Participants with nm downstream of exon 30, downstream of exon 45, and downstream of exon 63 had significantly lower normalized d-sf scores (p < 0.0001). Participants with nm downstream of exon 45 in addition had significantly lower normalized d-sb score (p < 0.04). There was no significant difference in the normalized d-sb score in participants with mutations upstream or downstream of DMD exon 30 or upstream or downstream of DMD exon 63. CONCLUSION: Our data provide evidence that specific cognitive deficits correlate to genotype in individuals with nmDMD, highlighting the critical role of brain-specific dystrophin isoforms in the neurobiological manifestations of this disease. CLINICALTRIALSGOV IDENTIFIER: NCT02090959.
Authors: Nathalie Doorenweerd; Chiara S Straathof; Eve M Dumas; Pietro Spitali; Ieke B Ginjaar; Beatrijs H Wokke; Debby G Schrans; Janneke C van den Bergen; Erik W van Zwet; Andrew Webb; Mark A van Buchem; Jan J Verschuuren; Jos G Hendriksen; Erik H Niks; Hermien E Kan Journal: Ann Neurol Date: 2014-07-24 Impact factor: 10.422
Authors: G Felisari; F Martinelli Boneschi; A Bardoni; M Sironi; G P Comi; M Robotti; A C Turconi; M Lai; G Corrao; N Bresolin Journal: Neurology Date: 2000-08-22 Impact factor: 9.910
Authors: Christophe Pichavant; Annemieke Aartsma-Rus; Paula R Clemens; Kay E Davies; George Dickson; Shin'ichi Takeda; Steve D Wilton; Jon A Wolff; Christine I Wooddell; Xiao Xiao; Jacques P Tremblay Journal: Mol Ther Date: 2011-04-05 Impact factor: 11.454
Authors: Joon Soo Lee; Zoltán Pfund; Csaba Juhász; Michael E Behen; Otto Muzik; Diane C Chugani; Michael A Nigro; Harry T Chugani Journal: Muscle Nerve Date: 2002-10 Impact factor: 3.217
Authors: Peter J Taylor; Grant A Betts; Sarah Maroulis; Christian Gilissen; Robyn L Pedersen; David R Mowat; Heather M Johnston; Michael F Buckley Journal: PLoS One Date: 2010-01-20 Impact factor: 3.240
Authors: Mathula Thangarajh; Jos Hendriksen; Michael P McDermott; William Martens; Kimberly A Hart; Robert C Griggs Journal: Neurology Date: 2019-10-08 Impact factor: 9.910